EMCDDA Case study 5 — Expanding HCV screening and hepatitis treatment and care for PWID to harm reduction centres

C. Devaux, V. Arendt

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

32 Downloads (Pure)

Fingerprint

Dive into the research topics of 'EMCDDA Case study 5 — Expanding HCV screening and hepatitis treatment and care for PWID to harm reduction centres'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases

Medicine and Dentistry